Prot# P10-023: A 10-Year, Post-Marketing, Observational, Registry of HUMIRA (Adalimumab) in Adult Patients With Chronic Plaque Psoriasis (Ps)

Project: Research project

StatusFinished
Effective start/end date4/20/098/31/19

Funding

  • United BioSource LLC (P10-023)
  • Abbott Laboratories (P10-023)